Psilera
PrivateLast Round
Seed
May 28, 2026
Total Funding Raised
$13.5M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Psilera is a biotechnology company that develops groundbreaking first-in-class treatments for neurological disorders by creating a new class of next-generation neuroplastogens.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Mental Health, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Psilera Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Psilera Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | May 28, 2026 | ||||
| Grant | Oct 2, 2025 | ||||
| Grant | Sep 5, 2024 | ||||
| Seed | Jul 1, 2021 |
Key People
Founding team and executive leadership
Psilera Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Baird Inc. | Seed |
| Receptor Partners | Seed |
| NIH RADx | Grant |
| Iter Investments | Seed |
| National Institute on Alcohol Abuse and Alcoholism | Grant |
| University of South Florida Research Foundation | Grant, Seed |
| What If Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 28, 2026
$9M raised in Seed funding.
- Jan 8, 2026
Magali Haas, MD/PhD, appointed to lead medical strategy.
Psilera Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Psilera's valuation, stock price, and market status.